This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
|Articles|September 6, 2011
Poll: Do You Routinely Use Compression Devices With C-section Patients?
Author(s)OBGYN.net Staff
ACOG has recently released “Thromboembolism in Pregnancy” in the September 2011 issue of 'Obstetrics & Gynecology' to guide clinicians in the prevention, management and treatment of blood clots during pregnancy.
Advertisement
ACOG has recently released “
Advertisement
Related to this article
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.
Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.
The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.
A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
Neither maternal MOUD dose nor umbilical cord opioid levels were associated with neonatal opioid withdrawal syndrome severity.
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
2
Diagnosing Sleep Disturbances Beyond VMS in Menopause
3
Reactions to FDA's boxed warning removals for menopausal hormone therapy
4
Top video interviews from The Menopause Society 2026 Annual Meeting
5